Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations

Clinical trial NCT06279130 · RECRUITING

Trial details

NCT number: NCT06279130
Sponsor: The Netherlands Cancer Institute
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Resectable MMR-deficient Solid Tumors Resectable MMR-proficient Solid Tumors

Start date: 2024-01-29
Primary completion: 2029-01-29
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.